REGN
Regeneron Pharmaceuticals Inc
$737.53
-0.65%
-4.78
Notify me if price changes either direction
Buy REGN stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
77.5B
Enterprise value
70.0B
Trailing PE
17.796331
Forward PE
13.96607
PEG Ratio
-4.7438344821875
Enterprise to EBITDA
16.498
Enterprise to revenue
4.884
Price to book MRQ
2.4207609
Price to sales TTM
5.4358773
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-12-31
Revenue (TTM)
14.3B
EBITDA
5.0B
Diluted EPS TTM
41.44
Total Cash (MRQ)
8.6B
Current ratio (MRQ)
4.126
Operating Cash Flow (TTM)
5.0B
REGN trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
March 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
